Pfizer Prepares for Potential Pharma Tariffs Under Second Trump Administration
Pfizer is prepared to adapt if pharmaceutical tariffs are introduced under a second Trump administration, CEO Albert Bourla, Ph.D., said at TD Cowen’s 45th annual healthcare conference in Boston. The company already operates 13 manufacturing sites across the U.S. and could